These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 28537056)

  • 1. Comparison of Antidiabetic Regimens in Patients with Type 2 Diabetes Uncontrolled by Combination Therapy of Sulfonylurea and Metformin: Results of the MOHAS Disease Registry in Korea.
    Choi SH; Oh TJ; Jang HC
    Diabetes Metab J; 2017 Jun; 41(3):170-178. PubMed ID: 28537056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin Initiation in Insulin-Naïve Korean Type 2 Diabetic Patients Inadequately Controlled on Oral Antidiabetic Drugs in Real-World Practice: The Modality of Insulin Treatment Evaluation Study.
    Kim SS; Kim IJ; Kim YK; Yoon KH; Son HY; Park SW; Sung YA; Baek HS
    Diabetes Metab J; 2015 Dec; 39(6):481-8. PubMed ID: 26616594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of bromocriptine-QR therapy on glycemic control in subjects with type 2 diabetes mellitus whose dysglycemia is inadequately controlled on insulin.
    Chamarthi B; Cincotta AH
    Postgrad Med; 2017 May; 129(4):446-455. PubMed ID: 28374645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exenatide once weekly versus daily basal insulin as add-on treatment to metformin with or without a sulfonylurea: a retrospective pooled analysis in patients with poor glycemic control.
    Grimm M; Li Y; Brunell SC; Blase E
    Postgrad Med; 2013 Sep; 125(5):101-8. PubMed ID: 24113668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin-Insulin versus Metformin-Sulfonylurea Combination Therapies in Type 2 Diabetes: A Comparative Study of Glycemic Control and Risk of Cardiovascular Diseases in Addis Ababa, Ethiopia.
    Gebrie D; Manyazewal T; A Ejigu D; Makonnen E
    Diabetes Metab Syndr Obes; 2021; 14():3345-3359. PubMed ID: 34335036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.
    Diabetes; 1995 Nov; 44(11):1249-58. PubMed ID: 7589820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of glycemic control in patients with type 2 diabetes mellitus treated with metformin-sulfonylurea combination: Results of a multicenter, cross-sectional, observational study in Korea.
    Kim SG; Hahm JR; Kim DK; Cho SR; Choi DS
    J Diabetes Investig; 2015 May; 6(3):317-24. PubMed ID: 25969717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and Severity of Hypoglycemia in Type 2 Diabetes Mellitus Patients Treated with a Sulfonylurea-Based Regimen at University-Affiliated Hospitals in Korea: The Naturalistic Evaluation of Hypoglycemic Events in Diabetic Subjects Study.
    Kim YS; Cho BL; Kim WS; Kim SH; Jung IH; Sin WY; Choi DH; Lee SJ; Lim CS; Kang KP; Yu BY; Jeung W; Park CG
    Korean J Fam Med; 2019 Jul; 40(4):212-219. PubMed ID: 31344994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. rs622342 in
    Naja K; Salami A; El Shamieh S; Fakhoury R
    J Pers Med; 2020 Jun; 10(2):. PubMed ID: 32575674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of glycemic control of patients with diabetes in Korea: the fifth Korea national health and nutrition examination survey.
    Jeon JY; Kim DJ; Ko SH; Kwon HS; Lim S; Choi SH; Kim CS; An JH; Kim NH; Won JC; Kim JH; Cha BY; Song KH;
    Diabetes Metab J; 2014 Jun; 38(3):197-203. PubMed ID: 25003073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Medley Correlation of Serum Zinc with Glycemic Parameters in T2DM Patients.
    Naik SK; Ramanand SJ; Ramanand JB
    Indian J Endocrinol Metab; 2019; 23(2):188-192. PubMed ID: 31161101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight loss in patients with diabetes treated with a metformin-sulfonylurea combination in comparison with twice-daily mixed insulin.
    Bell DS; Mayo MS
    Endocr Pract; 1998; 4(6):360-4. PubMed ID: 15251708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of metformin-facilitated reinitiation of oral diabetic therapy in insulin-treated patients with non-insulin-dependent diabetes mellitus.
    Bell DS; Mayo MS
    Endocr Pract; 1997; 3(2):73-6. PubMed ID: 15251479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of variable antidiabetic treatments strategy on oxidative stress markers in obese patients with T2DM.
    ALrefai AA; Alsalamony AM; Fatani SH; Kamel HFM
    Diabetol Metab Syndr; 2017; 9():27. PubMed ID: 28546831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why not adding a glucose-lowering agent with proven cardioprotection in high-risk patients with type 2 diabetes at HbA1c target on metformin?
    Scheen AJ
    Diabetes Res Clin Pract; 2019 Jan; 147():169-171. PubMed ID: 30391502
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes.
    Derosa G; D'Angelo A; Romano D; Maffioli P
    Drug Des Devel Ther; 2017; 11():1481-1488. PubMed ID: 28553078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, non-inferiority trial evaluating the efficacy and safety of omarigliptin, a once-weekly DPP-4 inhibitor, or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy.
    Handelsman Y; Lauring B; Gantz I; Iredale C; O'Neill EA; Wei Z; Suryawanshi S; Kaufman KD; Engel SS; Lai E
    Curr Med Res Opin; 2017 Oct; 33(10):1861-1868. PubMed ID: 28548024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes.
    Han E; Kim G; Lee JY; Lee YH; Kim BS; Lee BW; Cha BS; Kang ES
    Endocrinol Metab (Seoul); 2017 Jun; 32(2):274-280. PubMed ID: 28685516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.